WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Saturday, April 29, 2017 
Add Press Release News | News Feeds Feeds | Email This News Email

Drug-Eluting Stents Market 2015-2022 - Global Strategic Business Report 2017 - High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and Stents - Research and Markets
Friday, February 17, 2017

DUBLIN, Feb 17, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Drug-Eluting Stents - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Drug-Eluting Stents in US$ Million.

The report profiles 35 companies including many key and niche players such as

    --  Abbott Laboratories (US)
    --  AlviMedica (Turkey)
    --  Arterius Limited (UK)
    --  B. Braun Melsungen AG (Germany)
    --  Biosensors International Group, Ltd. (Singapore)
    --  Shandong JW Medical Systems LTD. (China)
    --  Biotronik SE & Co. KG (Germany)
    --  Boston Scientific Corporation (US)
    --  Cook Medical Inc. (US)
    --  Elixir Medical Corp. (US)
    --  KYOTO MEDICAL PLANNING Co., Ltd. (Japan)
    --  Lepu Medical Technology (Beijing) Co., Ltd. (China)
    --  Medtronic plc (Republic of Ireland)
    --  Micell Technologies, Inc. (US)
    --  Opto Circuits (India) Ltd (India)
    --  Eurocor GmbH (Germany)
    --  OrbusNeich Medical Company Limited (Hong Kong)
    --  QualiMed (Germany)
    --  Shanghai MicroPort Medical (Group) Co., Ltd. (China)
    --  Sino Medical Sciences Technology Inc. (China)
    --  STENTYS SA (France)
    --  Terumo Corporation (Japan)

Key Topics Covered:

1. Industry Overview

2. Macro Growth Drivers

    --  Aging - A Key Market Driver
    --  Global Aging Population Demographic Statistics: Key Opportunity
    --  High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and

3. Coronary Stenting - An Insight

    1. Cardiovascular Diseases - A Brief Description
    2. Coronary Heart Disease
    3. Treatment Options for Coronary Artery Disease
    4. Percutaneous Transluminal Coronary Angioplasty (PTCA)
    5. Coronary Artery Bypass Graft (CABG)
    6. Coronary Stenting
    7. How is Coronary Stenting Performed - Procedure
    8. Risks and Problems Associated with Placing a Stent
    9. Restenosis - A Major Challenge
    10. Cost and Price Economics of DES
    11. Cost Evaluation of DES
    12. Impact of DES on Indirect Costs

4. Product Launches & Approvals

    --  MicroPort Medical Receives Marketing Approval in Argentina for
        Firehawk® DES
    --  MicroPort Medical's Firehawk® DES Receives Marketing Approval in Brazil
    --  Biotronik Launches Biostem Clinical Trial for Orsiro Hybrid DES
    --  Boston Scientific's Eluvia DES System Receives CE Mark
    --  STENTYS Enters into Commercialization Agreements in Europe for
        below-the-knee arterial DES
    --  Medtronic Launches Expanded Sizes of Onyx DES and Expands Indications
    --  Svelte Medical Launches SLENDER Coronary Stent System in Europe
    --  Boston Scientific Receives FDA Approval for SYNERGY DES System
    --  Medtronic Launches Resolute Onyx DES in India

5. Recent Industry Activity

    --  Cordis Enters into Coronary Stent Sales Agreement with Biosensors
    --  MicroPort Scientific Acquires DES Assets and Intellectual Property from

6. Focus On Select Global Players

7. Global Market Perspective

Total Companies Profiled: 35 (including Divisions/Subsidiaries - 40)

- The United States (16)

- Japan (2)

- Europe (20)

- France (1)

- Germany (4)

- The United Kingdom (2)

- Rest of Europe (3)

- Asia-Pacific (Excluding Japan) (10)

- Middle East (1)

- Africa (1)

For more information about this report visit

Media Contact:

Research and Markets

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:

SOURCE Research and Markets

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav ZipHub Brings on Former Microsoft Veteran | Apr 29, 2017
Nav ProfNet Experts Available on Healthy Food Swaps, Lawncare Tips, More | Apr 28, 2017
Nav Global Probiotics Dietary Supplements (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula) Market Analysis 2014-2017 & 2025 - Research and Markets | Apr 28, 2017
Nav Global Bio-based Platform Chemicals Market to Grow at a CAGR of 10.88% by 2021: Growing R&D Expenditure is a Major Trend - Research and Markets | Apr 28, 2017
Nav SunExpress Well Positioned in the Digital Sales World With IBS Software's Platform | Apr 28, 2017
Nav Baking Ingredients Market to Reach USD 16.91 Billion by 2022: Growing Customer Demand for Healthier Foods, Convenience Foods & Functional Baked Goods -- Research and Markets | Apr 28, 2017
Nav India Premium Motorcycles (500 to 800cc, 800 to 1600cc and >1600cc) Market, Competition Forecast & Opportunities, 2011-2021 - Research and Markets | Apr 28, 2017
Nav Digital Marketing Agency, fishbat, Discusses What to Look for in a Real Estate Advertising Agency | Apr 28, 2017
Nav Electric Power Distribution Automation Systems Market Analysis By Implementation, Application, Region And Segment Forecasts, 2014 - 2025 - Research and Markets | Apr 28, 2017
Nav Research and Markets - Global Micro Guide Catheters Market to Grow at a CAGR of 8.75% by 2021: Key Vendors are Terumo, Boston Scientific, Merit Medical, Medtronic & ASAHI INTECC | Apr 28, 2017

Submit News | View More News View More News